|
HS (n = 17)
|
Pts (n = 30)
|
---|
| |
P* vs Pts
| | |
P**
|
---|
| |
Visit 1
|
Visit 2
|
Visit 1
|
Visit 2
|
Visit 2 vs 1
|
---|
Tot-c (mg/dL)
|
198.0 (188.5–221.5)
|
<0.0001
|
0.036
|
269.0 (226.0–318.0)
|
166.0 (141.5–204.5)
|
<0.0001
|
LDL-c (mg/dL)
|
115.0 (107.0–147.5)
|
0.003
|
n.s.
|
168.0 (119.3–263.5)
|
135.0 (94.0–196.5)
|
0.0013
|
HDL-c (mg/dL)
|
53.0 (44.0–67.5)
|
n.s.
|
n.s.
|
49.5 (42.8–56.3)
|
47.0 (39.5–54.5)
|
n.s.
|
TG (mg/dL)
|
132.0 (102.5–163.5)
|
0.002
|
0.0004
|
181.5 (137.7–220.6)
|
87.0 (61.2–111.9)
|
<0.0001
|
ApoA (mg/dL)
|
144.0 (121.5–161.0)
|
n.s.
|
n.s.
|
126.0 (114.3–139.5)
|
130.0 (112.0–143.5)
|
n.s.
|
ApoB (mg/dL)
|
98.0 (85.0–108.5)
|
<0.0001
|
0.038
|
139.0 (120.0–155.0)
|
80.0 (64.0–.98.0)
|
<0.0001
|
hs-CRP (mg/L)
|
1.50 (0.60–2.70)
|
n.s.
|
n.s.
|
0.90 (0.45–2.20)
|
1.1 (0.7–2.4)
|
n.s.
|
Glucose (mg/dL)
|
96 (89–97)
|
n.s.
|
n.s.
|
93.5 (89.75–102)
|
96 (89.75–100)
|
n.s.
|
- Values are expressed as median and 25–75th percentile
-
n.s. not significant
- * = Mann Whitney test; ** = Wilcoxon signed rank test